- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Frankfurt | 90,770 | 04.07.24 16:41:49 | -0,210 | -0,23% | 90,910 | 91,090 | 90,680 | 90,980 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 944,800 | 04.07.24 08:04:14 | +8,200 | +0,88% | 944,000 | 950,000 | 944,800 | 936,600 |
